Brief: BioArctic Q3 Operating Profit SEK -26.1 Million
14/11/2024 07:01
Nov 14 (Reuters) - BioArctic Q3 revenue SEK 76.6 million. * Q3 net income SEK -19.6 million * Q3 adjusted EPS SEK -0.22 * Q3 adjusted free cash flow SEK -80.3 million
Recent news on BioArctic AB (publ)
See all newsBrief: BioArctic Gets Leqembi Pen Subcutaneous Formulation Approval In Japan
Brief: BioArctic Says Leqembi Subcutaneous Formulation Approved For Initiation Treatment In China
Brief: BioArctic Says Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of Leqembi
Sweden's BioArctic Q2 revenue falls despite higher Leqembi royalties
Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln